Clinical trials
Urinary Bladder Neoplasms trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
130 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 5 |
| 2015 | 5 |
| 2016 | 5 |
| 2017 | 5 |
| 2018 | 12 |
| 2019 | 14 |
| 2020 | 13 |
| 2021 | 14 |
| 2022 | 9 |
| 2023 | 5 |
| 2024 | 6 |
| 2025 | 9 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 56 |
| Active, not recruiting | 26 |
| Recruiting | 23 |
| Terminated | 18 |
| Unknown status | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 10 |
| AstraZeneca | 9 |
| Bristol-Myers Squibb | 7 |
| Eli Lilly and Company | 6 |
| Hoffmann-La Roche | 6 |
| Janssen Research & Development, LLC | 6 |
| Pfizer | 6 |
| UroGen Pharma Ltd. | 4 |
| Astellas Pharma Global Development, Inc. | 3 |
| Bayer | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urinary Bladder Neoplasms | 130 |
| Carcinoma, Transitional Cell | 32 |
| Carcinoma, Non-Small-Cell Lung | 19 |
| Ovarian Neoplasms | 17 |
| Non-Muscle Invasive Bladder Neoplasms | 13 |
| Squamous Cell Carcinoma of Head and Neck | 12 |
| Stomach Neoplasms | 12 |
| Uterine Cervical Neoplasms | 12 |
| Colorectal Neoplasms | 11 |
| Esophageal Neoplasms | 11 |
Trials
Showing 26 to 50 of 130. Each trial links to its page on Pharma Observatory.
30 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.